We are live on
!
Find out more
GAA
Green Alpha Advisors Portfolio holdings
AUM
$148M
Turnover
14.17%
1-Year Est. Return
98.22%
This Fund
S&P 500
This Quarter
Est. Return
+21.29%
1 Year Est. Return
+98.22%
3 Year Est. Return
+315.88%
5 Year Est. Return
+340.2%
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$11.1M
(+12%)
Cap. Flow
-$4.32M
Cap. Flow
% of AUM
-4.13%
Top 10 Holdings %
Top 10 Hldgs %
37.08%
Holding
112
New
–
Increased
5
Reduced
104
Closed
3
Avg Time Held
3.2
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Horizon Technology Finance
HRZN
|
+$226K |
| 2 |
Moderna
MRNA
|
+$68.4K |
| 3 |
Vail Resorts
MTN
|
+$49.5K |
| 4 |
CRISPR Therapeutics
CRSP
|
+$42.6K |
| 5 |
Steelcase
SCS
|
+$38.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twist Bioscience
TWST
|
+$238K |
| 2 |
Tempus AI
TEM
|
+$226K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$218K |
| 4 |
Vitamin Cottage Natural Grocers
NGVC
|
+$209K |
| 5 |
Radius Recycling
RDUS
|
+$179K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 52.13% |
| 2 | Healthcare | 12.72% |
| 3 | Consumer Staples | 11.23% |
| 4 | Consumer Discretionary | 7.41% |
| 5 | Industrials | 6.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Intellia Therapeutics
NTLA
$1.6B
| $103K | 0.1% |
11,007
-1,461
| -12% | -$12K |
2024 Q4
2 quarters
|
|
102
DELISTED
CureVac
CVAC
| $102K | 0.1% |
18,743
-7,128
| -28% | -$28.3K |
2022 Q2
12 quarters
|
|
103
AbCellera Biologics
ABCL
$3.82B
| $99.8K | 0.1% |
29,103
-8,347
| -22% | -$20.8K |
2021 Q3
15 quarters
|
|
104
Shoals Technologies Group
SHLS
$1.21B
| $84.5K | 0.08% |
19,877
-4,436
| -18% | -$19.3K |
2022 Q2
12 quarters
|
|
105
Energy Vault
NRGV
$516M
| $60.5K | 0.06% |
84,450
-18,063
| -18% | -$14.6K |
2022 Q2
12 quarters
|
|
106
Beam Global
BEEM
$20.2M
| $31.8K | 0.03% |
21,789
-2,869
| -12% | -$4.58K |
2022 Q1
13 quarters
|
|
107
Wolfspeed
WOLF
$1.23B
| $27.4K | 0.03% |
68,681
-2,529
| -4% | -$5.77K |
2020 Q4
18 quarters
|
|
108
Metagenomi Therapeutics
MGX
$29.6M
| $27.3K | 0.03% |
18,458
-5,571
| -23% | -$8.72K |
2024 Q3
3 quarters
|
|
109
DELISTED
ESS Tech
GWH
| $16.5K | 0.02% |
12,381
-2,423
| -16% | -$4.53K |
2023 Q3
7 quarters
|
|
|
110
Regeneron Pharmaceuticals
REGN
$81.4B
| – | – |
-344
| Closed | -$218K | – |
|
|
111
Twist Bioscience
TWST
$8.8B
| – | – |
-6,064
| Closed | -$238K | – |
|
112
DELISTED
Li-Cycle Holdings Corp.
LICY
| – | – |
-56,371
| Closed | -$20.4K | – |
|
Similar funds
BM
LFWA
RLWM
ACM
BSTWA
NI
TWPM
AA
Green Alpha Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Green Alpha Advisors held 112 positions worth $105M, up 12% from $93.6M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Green Alpha Advisors withdrew a net $4.32M in Q2 2025, closing 3 positions and reducing 104 holdings. Its most notable exit was Twist Bioscience, an estimated $238K position sold in full.
By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Green Alpha Advisors added an estimated $226K to Horizon Technology Finance.
- Green Alpha Advisors added most to Horizon Technology Finance in Q2 2025, an estimated $226K increase.
- Green Alpha Advisors's biggest Q2 2025 reduction was Tempus AI, cutting an estimated $226K.
- Green Alpha Advisors fully exited Twist Bioscience in Q2 2025, selling an estimated $238K.
- Green Alpha Advisors's ten largest holdings make up 37% of its $105M portfolio in Q2 2025.
- Green Alpha Advisors opened 0 new positions and closed 3 in Q2 2025.
- Green Alpha Advisors's portfolio value rose 12% quarter-over-quarter to $105M.
Based on Green Alpha Advisors's 13F filing for Q2 2025, filed 1 Aug 2025.